Xeris Biopharma Holdings, Inc. (0A8E.L) LSE
5.95
+0.094(+1.61%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.26B |
| Enterprise Value | 1.19B |
| P/E Ratio | 1,782.44 |
| PEG Ratio | 4.85 |
| Price/Sales Ratio | 3.52 |
| Price/Book Ratio | 72.14 |
| Enterprise/Revenue | 3.26 |
| Enterprise/EBITDA | 27.2 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0.09 |
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | -0.05 |
Income Statement
| Revenue | 291.85M |
| Revenue/Share | 1.76 |
| Gross Profit | 238.43M |
| EBITDA | 12.71M |
| Net Income | 554,000 |
| Diluted EPS | 0 |
Balance Sheet
| Total Cash | 111.04M |
| Total Cash/Share | 0.67 |
| Total Debt | 37.76M |
| Total Debt/Equity | 2.76 |
| Current Ratio | 2.19 |
| Book Value Per Share | 0.08 |
Price History
| 52-Week Change | 44.39 |
| 52-Week High | 6.04 |
| 52-Week Low | 1.28 |
| Moving Average 50 Days | 2.68 |
| Moving Average 200 Days | 2.36 |
Statistics
| Average Volume | 8,763 |
| Shares Outstanding | 160.44M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
